PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma.
Shi-Zhe ZhangXiao-Dong ZhuLong-Hai FengXiao-Long LiXue-Feng LiuHui-Chuan SunZhao-You TangPublished in: Experimental hematology & oncology (2021)
PCSK9 expression level in HCC is an indicator of poor prognosis for patients with HCC. FASN-mediated anti-apoptosis plays an important role in PCSK9-induced HCC progression.